C. Luna (Buenos Aires, Argentina), M. Sucena (Leca Da Palmeira, Portugal), S. Krueger (Aachen, Germany), A. Hill (Edinburgh, United Kingdom)
Bacteriological analysis of lower respiratory tract in patients with rheumatoid arthritis and other collagen vascular diseases
K. Akata, S. Nagata, T. Kido, K. Yamasaki, T. Kawanami, H. Ishimoto, K. Yatera, H. Mukae (KItakyusyu, Japan)
|  |
CURB 65 or CURB (S) 65 for community acquired pneumonia?
S. Nazik, N. Köktürk, A. Baha, N. Ekim (Ankara, Turkey)
| |
Do physicians use urinary pneumococcal antigen test (UPAT) appropriately?
V. Palissery, A. Kamath, C. Tremlett (Norwich, United Kingdom)
|  |
A clinical, radiological and microbiological profile of lung abscess
M. Malik, S. Ghazal, A. Kumara, N. Rizvi (Karachi, Pakistan)
| |
The comparison of different methods of etiologic diagnosis of community-acquired pneumonia
K. Zykov, A. Rvacheva, E. Kaznacheeva, A. Pustovalov, G. Khaptkhaeva, A. Chuchalin, E. Sokolov (Moscow, Russian Federation)
| |
Prevalence of MRSA nasal carrier rate in hematology patients of Benghazi Medical Center using PCR-based method; first study in Libya
K.A. Gaber, W.A. Eldukali, F.S. Al-Jehani (Benghazi, Libyan Arab Jamahiriya)
| |
Influence of age in the clinical differentiation of atypical pneumonia in adults
N. Miyashita, Y. Kawai, M. Kubo, K. Ouchi, N. Okimoto (Okayama, Japan)
| |
Clinical features and prognostic factors in elderly patients with aspiration pneumonia
S.W. Kim, Y.J. Ryu, S.J. Lee, J.H. Lee, J.H. Chang, S.S. Shim (Seoul, Republic Of Korea)
| |
Incidence of ventilator associated pneumonia (VAP) and assessment of serial estimation of procalcitonin levels as a prognostic marker in cases of VAP in a tertiary centre in India
V. Sikri, R. Chawla, R. Sardana, A. Jain (New Delhi, India)
| |
Procalcitonin and proadrenomedullin in COPD patients: Stable state versus exacerbation difference in mortality rate?
M.C. Telgen, M.G.J. Brusse-Keizer, P.D.L.P.M. van der Valk, J. van der Palen, H.A.M. Kerstjens, M.G.R. Hendrix (Enschede, Netherlands)
| |
Red cell distribution wide (RDW) as severity biomarker in patients with community-adquired pneumonia (CAP)
S. Fandos, E. Minchole, A. Simon, C. Panadero, A. Lasierra, G. Hernandez, C. Lapresta, S. Bello (Zaragoza, Spain)
| |
Pleural fluid C-reactive protein concentration in discriminating uncomplicated from complicated parapneumonic pleural effusion
S. Petrusevska Marinkovic, I. Kondova Topuzovska, Z. Milenkovic, G. Kondov, A. Anastasovska, L. Stojanova (Skopje, Fyrom)
| |
Lung and serum biomarkers of tissue lesions due to acute exacerbation of COPD
K. Mise, Z. Ivancevic, I. Gudelj, S. Kotarac, J. Svalina-Grmusa (Split, Croatia)
| |
Elevated creatinine is a sensitive severity marker in community acquired pneumonia
J. Sloan, J. Wilson, C. Griffin, M. Wilkie, J. Chalmers, S. Schembri (Dundee, United Kingdom)
| |
Admission hyperglycaemia is associated with increased risk of diabetes mellitus following hospitalisation with community acquired pneumonia
A. Singanayagam, G. Fleming, A. Akram, A. Hill, J. Chalmers (London, United Kingdom)
| |
Risk factors in readmission of patients with community-acquired pneumonia discharged from the emergency department
E. Vázquez-Espinosa, R.M. Gómez-Punter, J.A. Gª Romero de Tejada, J. Aspa Marco, O. Rajas Naranjo (Madrid, Spain)
| |
Study on human tracheal bronchial epithelial cells secreting cytokines in vitro by nontypeable haemophilus influenzae
J. Qian, C. Bai, G. Wang (Shanghai, Kunshan, China)
| |
Comparision of procalcitonin and CURB-65 in pneumonia
S. Ozsu, I. Yilmaz, Y. Abul, F. Öztuna, Y. Bulbul, T. Ozlu (Trabzon, Turkey)
| |
Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease
F. Chermiti Ben Abdallah, W. Bouhawel, I. Sahnoun, R. Mahouachi, A. Chtourou, S. Taktak, A. Ben Kheder (Ariana, Tunisia)
| |
Influence of lung infection on the course and outcome in patients with stroke
D. Ristic, S. Ristic, I. Marinkovic, I. Veselinovic (Nis, Republic Of Serbia)
| |